参考文献/References:
[1] Yin C, Evason KJ, Asahina K, et al. Hepatic stellate cells in liver development, regeneration, and cancer[J]. J Clin Invest,2013, 123:1902- 1910.
[2] Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease[J]. Nat Med, 2012, 18:1028- 1040.
[3] Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis[J]. Lancet, 2014, 383:1749- 1761.
[4] Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis[J]. J Hepatol, 2012, 56:1171- 1180.
[5] Solis- Herruzo JA, Solis- Munoz P, Munoz Yague T, et al. Molecular targets in the design of antifibrotic therapy in chronic liver disease[J]. Rev Esp Enferm Dig, 2011, 103:310- 323.
[6] Brun P, Castagliuolo I, Pinzani M, et al. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells[J]. Am J Physiol Gastrointest Liver Physiol, 2005,289:G571- G578.
[7] 朱 楠,张甜甜,吕维富, 等. 诱导型一氧化氮合酶、血小板衍生生长因子- B和脂多糖在布- 加综合征大鼠模型中的表达及意义[J]. 介入放射学杂志, 2019, 28:262- 267.
[8] 伍振辉,孟 娴,胡佳伟, 等. TLR4- MyD88- NF- kB信号通路与肝炎- 肝纤维化- 肝癌轴相关性研究进展[J]. 国际药学研究杂志, 2017, 44:396- 401.
[9] Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation[J]. Nat Rev Gastroenterol Hepatol, 2017, 14:527- 539.
[10] Bai T, Lian LH, Wu YL, et al. Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells[J]. Int Immunopharmacol, 2013, 15:275- 281.
[11] Su H, Wang Y, Gu Y, et al. Potential applications and human biosafety of nanomaterials used in nanomedicine[J]. J Appl Toxicol,2018, 38:3- 24.
[12] 李 鑫,刘凤永,袁宏军, 等. 纳米刀治疗肝癌[J]. 介入放射学杂志, 2017, 26:939- 943.
[13] Boussif O, Lezoualc’h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine[J]. Proc Natl Acad Sci USA, 1995, 92:7297- 7301.
[14] Shen M, Gong F, Pang P, et al. An MRI- visible non- viral vector for targeted Bcl- 2 siRNA delivery to neuroblastoma[J]. Int J Nanomedicine, 2012, 7:3319- 3332.
[15] Chen Y, Lian G, Liao C, et al. Characterization of polyethylene glycol- grafted polyethylenimine and superparamagnetic iron oxide nanoparticles(PEG- g- PEI- SPION) as an MRI- visible vector for siRNA delivery in gastric cancer in vitro and in vivo[J]. J Gastroenterol, 2013, 48:809- 821.
[16] Sato Y, Murase K, Kato J, et al. Resolution of liver cirrhosis using vitamin A- coupled liposomes to deliver siRNA against a collagen- specific chaperone[J]. Nat Biotechnol, 2008, 26:431- 442.
[17] Ito S, Nagata K. Biology of Hsp47(Serpin H1), a collagen- specific molecular chaperone[J]. Semin Cell Dev Biol, 2017, 62:142- 151.
[18] Yang X, Iyer AK, Singh A, et al. Cluster of differentiation 44 targeted hyaluronic acid based nanoparticles for MDR1 siRNA delivery to overcome drug resistance in ovarian cancer[J]. Pharm Res, 2015, 32:2097- 2109.
[19] Zhu Q, Zou L, Jagavelu K, et al. Intestinal decontamination inhibits TLR4 dependent fibronectin- mediated cross- talk between stellate cells and endothelial cells in liver fibrosis in mice[J]. J Hepatol, 2012, 56:893- 899.
[20] Liu M, Xu Y, Han X, et al. Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF- κB signaling pathway[J]. Sci Rep, 2015, 5:18038.
[21] Zhang P, An K, Duan X, et al. Recent advances in siRNA delivery for cancer therapy using smart nanocarriers[J]. Drug Discov Today, 2018, 23:900- 911..
[22] Qian C, Wang Y, Chen Y, et al. Suppression of pancreatic tumor growth by targeted arsenic delivery with anti- CD44v6 single chain antibody conjugated nanoparticles[J]. Biomaterials, 2013, 34:6175- 6184.
相似文献/References:
[1]李 苒,程芝梅,何慧洲,等.吡非尼酮通过抑制肝星状细胞自噬促进凋亡治疗肝纤维化[J].介入放射学杂志,2023,32(07):651.
LI Ran,CHENG Zhimei,HE Huizhou,et al.Pirfenidone treats liver fibrosis by inhibiting autophagy of hepatic stellate cells and promoting apoptosis[J].journal interventional radiology,2023,32(10):651.